193 related articles for article (PubMed ID: 37314412)
1.
Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
[TBL] [Abstract][Full Text] [Related]
2. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor.
Giri RK; Rajagopal V; Kalra VK
J Neurochem; 2004 Dec; 91(5):1199-210. PubMed ID: 15569263
[TBL] [Abstract][Full Text] [Related]
3. Development of a pseudovirus assay and evaluation to screen natural products for inhibition of HIV-1 subtype C reverse transcriptase.
Mavhandu LG; Cheng H; Bor YC; Tebit DM; Hammarskjold ML; Rekosh D; Bessong PO
J Ethnopharmacol; 2020 Aug; 258():112931. PubMed ID: 32360797
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and its analogues: a potential natural compound against HIV infection and AIDS.
Prasad S; Tyagi AK
Food Funct; 2015 Nov; 6(11):3412-9. PubMed ID: 26404185
[TBL] [Abstract][Full Text] [Related]
6. Isolation and In silico Study of Curcumin from Curcuma longa and Its Anti-Diabetic Activity.
Vaithiyalingam M; Sumathi DL; Sabarathinam S
Appl Biochem Biotechnol; 2023 Feb; 195(2):947-957. PubMed ID: 36242725
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic nanoparticles attenuate HIV-1 infectivity.
Hood JL; Jallouk AP; Campbell N; Ratner L; Wickline SA
Antivir Ther; 2013; 18(1):95-103. PubMed ID: 22954649
[TBL] [Abstract][Full Text] [Related]
8. Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability.
Abd El-Hack ME; El-Saadony MT; Swelum AA; Arif M; Abo Ghanima MM; Shukry M; Noreldin A; Taha AE; El-Tarabily KA
J Sci Food Agric; 2021 Nov; 101(14):5747-5762. PubMed ID: 34143894
[TBL] [Abstract][Full Text] [Related]
9. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.
Sadeghi M; Dehnavi S; Asadirad A; Xu S; Majeed M; Jamialahmadi T; Johnston TP; Sahebkar A
Inflammopharmacology; 2023 Jun; 31(3):1069-1093. PubMed ID: 36997729
[TBL] [Abstract][Full Text] [Related]
10. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives.
Tsuda T
Food Funct; 2018 Feb; 9(2):705-714. PubMed ID: 29206254
[TBL] [Abstract][Full Text] [Related]
11. Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s.
Nakata H; Maeda K; Das D; Chang SB; Matsuda K; Rao KV; Harada S; Yoshimura K; Ghosh AK; Mitsuya H
Sci Rep; 2019 Mar; 9(1):4828. PubMed ID: 30886166
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.
Cagnon L; Rossi JJ
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):251-61. PubMed ID: 10984119
[TBL] [Abstract][Full Text] [Related]
13. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
Soleimani V; Sahebkar A; Hosseinzadeh H
Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
[TBL] [Abstract][Full Text] [Related]
14. New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection.
Garcia-Perez J; Rueda P; Staropoli I; Kellenberger E; Alcami J; Arenzana-Seisdedos F; Lagane B
J Biol Chem; 2011 Feb; 286(7):4978-90. PubMed ID: 21118814
[TBL] [Abstract][Full Text] [Related]
15. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
16. Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.
Rogers NM; Kireta S; Coates PT
Clin Exp Immunol; 2010 Dec; 162(3):460-73. PubMed ID: 21070208
[TBL] [Abstract][Full Text] [Related]
17. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Eo SK
J Neuroinflammation; 2016 Jul; 13(1):223. PubMed ID: 27439902
[TBL] [Abstract][Full Text] [Related]
18. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen.
Mahady GB; Pendland SL; Yun G; Lu ZZ
Anticancer Res; 2002; 22(6C):4179-81. PubMed ID: 12553052
[TBL] [Abstract][Full Text] [Related]
19. Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G
J Gene Med; 2018 Feb; 20(2-3):e3006. PubMed ID: 29552747
[TBL] [Abstract][Full Text] [Related]
20. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
